<?xml version="1.0" encoding="UTF-8"?>
<!-- This is a template for a FHIR resource, and needs items (marked with "${}") replacing to make a real instance -->
<!-- The resulting instance is a Bundle of Bundles, each of which is a document (having a Composition, and supporting resources) -->
<!-- 2020-02-22 -->
<!-- This is for FHIR version R5 Preview 2 (May 2020) -->
<Bundle xmlns="http://hl7.org/fhir">
	<type value="collection"/>
	<!-- Repeat at this level per document -->
	<entry>
		<fullUrl value="urn:uuid:5e38c9a4-c9e0-4dc8-9f52-a8cc909e25c7"/>
		<!-- Top level of each document is a also FHIR Bundle, of type "document"
		 see http://hl7.org/fhir/documents.html, http://hl7.org/fhir/bundle.html
	 	 All the other resources for this document are within this. -->
		<resource>
            <Bundle>
            	<!-- When PUTing, some servers mandate an id here to match the existing id -->
            	<id value="e312755e-2ca8-47dc-a6d4-405e0aa5e605"/>
				<!-- document bundles must have an identifier (bdl-9) -->
				<identifier>
					<!-- possibly different identifier types may be needed here -->
					<system value="http://ema.europa.eu/fhir/identifier/documentid"/>
					<value value="${instance.bundle[n].Identifier}"/>
				</identifier>
				<!-- fixed code -->
				<type value="document" /> 
            	<!-- document bundles must have a date (bdl-10) -->
            	<timestamp value="2021-05-10T23:03:30Z"/>
				<!-- a repeating set of entry elements, each with a FHIR resource inside -->
				<entry>
					<!-- fullUrl is mandatory for each entry in document Bundle. It is a random uuid. http://build.fhir.org/bundle.html#bundle-unique -->
					<fullUrl value="urn:uuid:29f016b1-783c-4624-a05b-b3fd4167514f"/>
					<resource>
						<!-- the first resource must be Composition (bdl-11) -->
						<!-- This is the overall document structure. -->
						<!-- see definition http://hl7.org/fhir/composition.html, and similar for other resources -->
                        <Composition>
                        	<!-- images if requied within html text of this document -->
							
							<contained>
                                <Binary>
                                	<id value="image0"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image002.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image002.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image0"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image1"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image003.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image003.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image1"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image2"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image004.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image004.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image2"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image3"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image005.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image005.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image3"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image4"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image004.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image004.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image4"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image5"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image005.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image005.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image5"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image6"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image006.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image006.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image6"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image7"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image007.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image007.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image7"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image8"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image008.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image008.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image8"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image9"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image009.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image009.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image9"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image10"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image010.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image010.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image10"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image11"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image011.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image011.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image11"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image12"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image004.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image004.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image12"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image13"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image005.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image005.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image13"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image14"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image004.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image004.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image14"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image15"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image005.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image005.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image15"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image16"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image012.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image012.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image16"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image17"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image013.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image013.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image17"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image18"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image014.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image014.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image18"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image19"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image015.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image015.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image19"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image20"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image016.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image016.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image20"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image21"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image017.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image017.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image21"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image22"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image018.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image018.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image22"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image23"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image019.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image019.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image23"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image24"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image020.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image020.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image24"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image25"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image021.jpg"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image021.jpg"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image25"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image26"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image022.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image022.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image26"/>
                        		</valueReference>
               </extension>
              
							<contained>
                                <Binary>
                                	<id value="image27"/>
                                	<!-- example format -->
                                	<contentType value="AbilifyMaintena-h-2755-e_files/image022.png"/>
									<!-- data is base 64 encoded, actual bytes of the image png file -->
                                	<data value="AbilifyMaintena-h-2755-e_files/image022.png"/>
								</Binary>
							</contained>
							<!-- this exension is necessary per image -->
                <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                        		<valueReference>
                        			<reference value="#image27"/>
                        		</valueReference>
               </extension>
              
              
              <contained>
                          <Binary>
                            <id value="stylesheet0"/>
                            <!-- example format -->
                            <contentType value="stylesheet/css"/>
                            <!-- data is base 64 encoded, actual bytes of the image png file -->
                            <data value="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"/>
                          </Binary>
                        </contained>
                        <!-- this exension is necessary per image -->
                        <extension url="http://ema.europa.eu/fhir/extension/dummyValidationReference">
                          <valueReference>
                            <reference value="#stylesheet0"/>
                          </valueReference>
                        </extension>
              
              <status value="final"/>
							<!-- document type -->
							<type>
								<coding>
									<system value="http://spor.ema.europa.eu/v1/lists/100000155531"/>
									<code value="${document[n].documentTypeCode}"/>
									<display value="${document[n].documentTypeDisplay}"/>
								</coding>
							</type>
							<subject>
								<!-- links to the List resource in this bundle - local url format -->
								<reference value="[]"/> <!-- local url format -->
								<!--reference value="${instance.bundle[n].listUuid}"/--> <!-- uuid url format. Possible alternate format may be neeed -->
							</subject>
                        	<!-- mandatory date of the document -->
                        	<date value="2021-02-01"/>
							<author>
								<identifier>
									<system value="http://spor.ema.europa.eu/v1/locations" />
									<value value="" />
								</identifier>
							</author>
                        	<title value="${document[n].title}"/>
							<relatesTo>
								<code value="appends"/>
								<targetReference>
									<!-- reference to another Composition -->
									<reference value="${document[n].relatesTo}"/>
								</targetReference>
							</relatesTo>
							<!-- main sections of the document, to follow the QRD template -->
	               			
<section>
	
		
			<title value="B. PACKAGE LEAFLET"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p align="center" class="MsoNormal" style="text-align:center"></p><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Package leaflet: Information for the user</span></b></em></p><p class="MsoNormal"></p><p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">300 mg powder and solvent for prolonged-release suspension for injection</span></em></span></b></p><p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">400 mg powder and solvent for prolonged-release suspension for injection</span></em></span></b></p><p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">aripiprazole</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Read all of this leaflet carefully before you receive this medicine because it contains important information for you.</span></b></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Keep this leaflet. You may need to read it again.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        If you have any further questions, ask your doctor or nurse.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.</span></em></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What is in this leaflet</span></b></em></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">1.       What </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is and what it is used for</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">2.       What you need to know before you are given </span></em><span lang="EN-GB" style="color:black">Abilify Maintena</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">3.       How </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is given</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">4.       Possible side effects</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">5.       How to store </span></em><span lang="EN-GB" style="color:black">Abilify Maintena</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">6.       Contents of the pack and other information</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">1.       What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is and what it is used for</span></em></span></b></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat schizophrenia - a disease with symptoms such as hearing, seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness. People with this condition may also feel depressed, guilty, anxious or tense.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">is intended for adult patients with schizophrenia who are sufficiently stabilised during treatment with oral aripiprazole.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"></p>
			</div>
		</text>
		
		
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you are given Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Do not use Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•</span></em><em><span lang="EN-GB" style="color:black;font-style:normal">        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Warnings and precautions</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Talk to your doctor or nurse before you are given </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Suicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you are having any thoughts or feelings about hurting yourself.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Before treatment with </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">, tell your doctor if you suffer from</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        an acutely agitated state or a severely psychotic state</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        heart problems or have a history of stroke, especially if you know that you have other risks factors for stroke</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        high blood sugar (characterised by symptoms such as excessive thirst, passing of large amounts of urine, increase in appetite and feeling weak) or family history of diabetes</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        fits (seizures) since your doctor may want to monitor you more closely</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        involuntary, irregular muscle movements, especially in the face</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">experience a combination of fever, sweating, faster breathing, muscle stiffness and drowsiness or sleepiness (may be signs of neuroleptic malignant syndrome)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dementia (loss of memory and other mental abilities) especially if you are elderly</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        cardiovascular diseases (diseases of the heart and circulation), family history of cardiovascular disease, stroke or "mini" stroke, abnormal blood pressure</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        irregular heart beat or if someone else in your family has a history of irregular heart beat (including so called QT prolongation seen with ECG monitoring).</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        blood clots, or family history of blood clots, as antipsychotics have been associated with formation of blood clots</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">have any difficulty in swallowing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        past experience with excessive gambling</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        severe liver problems.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you notice you are gaining weight, develop unusual movements, experience sleepiness that interferes with normal daily activities, any difficulty in swallowing or have allergic symptoms, please talk to your doctor immediately.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB">Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings.</span></p><p class="MsoNormal"><u><span lang="EN-GB">Your doctor may need to adjust or stop your dose.</span></u></p><p class="MsoNormal"><u><span lang="EN-GB"></span></u></p><p class="MsoNormal"><span lang="EN-GB">Aripiprazole may cause sleepiness, fall in blood pressure when standing up, dizziness and changes in your ability to move and balance, which may lead to falls. Caution should be taken, particularly if you are an elderly patient or have some debility.</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><span lang="EN-GB" style="color:black">Do not use this medicine in children and adolescents under 18 years of age. It is not known if it is safe and effective in these patients.</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other medicines and Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tell your doctor if you are taking, have recently taken or might take any other medicines.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Blood pressure-lowering medicines:</span></em><span lang="EN-GB" style="color:black"> Abilify Maintena <em><span style="font-style:normal">may increase the effect of medicines used to lower the blood pressure. Be sure to tell your doctor if you take a medicine to keep your blood pressure under control.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">with some medicines may mean the doctor will need to change your dose of </span></em>Abilify Maintena <em><span style="font-style: normal">or the other medicines. It is especially important to mention the following to your doctor:</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        medicines to correct heart rhythm (such as quinidine, amiodarone, flecainide)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        antidepressants or herbal remedy used to treat depression and anxiety</span></em><span class="berschrift4Zchn"></span><span class="berschrift4Zchn"><span lang="EN-GB" style='font-family:"Times New Roman",serif;color:black;font-weight:normal'>(</span></span><em><span lang="EN-GB" style="color:black;font-style:normal">such as fluoxetine, paroxetine, St. John's Wort)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        antifungal medicines (such as ketoconazole, itraconazole)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        certain medicines to treat HIV infection (such as efavirenz, nevirapine, and protease inhibitors e.g. indinavir, ritonavir)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        anticonvulsants used to treat epilepsy (such as </span></em><span class="BMSHeading3Char"><span lang="EN-GB" style='font-family:"Times New Roman",serif;font-weight:normal'>carbamazepine, phenytoin,</span></span><span class="BMSHeading3Char"></span><em><span lang="EN-GB" style="color:black;font-style:normal">phenobarbital)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        certain antibiotics used to treat tuberculosis (rifabutin, rifampicin)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        medicines that are known to prolong QT prolongation.</span></em></p><p class="EMEABodyText"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt">These medicines may increase the risk of side effects or reduce the effect of <span style="color:black">Abilify Maintena</span>; if you get any unusual symptom taking any of these medicines together with <span style="color:black">Abilify Maintena</span>, you should see your doctor.</span></p><p class="EMEABodyText"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt;color:black">Medicines that increase the level of serotonin </span><span class="BMSHeading3Char"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; font-weight:normal'>are typically used in conditions including depression, generalised anxiety disorder, obsessive-compulsive disorder (OCD) and social phobia as well as migraine and pain</span></span><span lang="EN-GB" style="font-size:11.0pt;color:black">:</span></p><p class="EMEABodyText"></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt">triptans, tramadol and tryptophan used for conditions including depression, generalised anxiety disorder, obsessive compulsive disorder (OCD) and social phobia as well as migraine and pain</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">SSRI s (such as paroxetine and fluoxetine) used for depression, OCD, panic and anxiety</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">other anti-depressants (such as venlafaxine and tryptophan) used in major depression</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">tricyclic’s (such as clomipramine and amitriptyline) used for depressive illness</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">St John’s Wort (<i>Hypericum perforatum</i>) used as a herbal remedy for mild depression</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">painkillers (such as tramadol and pethidine) used for pain relief</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">triptans (such as sumatriptan and zolmitripitan) used for treating migraine.</span></p><p class="MsoNormal"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt">These medicines may increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with <span style="color:black">Abilify Maintena</span>, you should see your doctor.</span></p><p class="EMEABodyText"></p><p class="MsoNormal"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">with alcohol</span></em></span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Alcohol should be avoided.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Pregnancy, breast-feeding and fertility</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving this medicine.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">You should not be given </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">if you are pregnant unless you have</span></em></span></b><em><span lang="EN-GB" style="color:black;font-style: normal"> discussed this with your doctor. </span></em><span lang="EN-GB" style="color:black">Be sure to tell your doctor immediately if you are pregnant, think you may be pregnant, or if you are planning to become pregnant.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">The following symptoms may occur in new-born babies, of mothers that have received </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">in the last trimester (last three months of their pregnancy):</span></em></span></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If your baby develops any of these symptoms you need to contact your doctor.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you are receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">, your doctor will discuss with you whether you should breast-feed considering the benefit to you of your therapy and the benefit to your baby of breast-feeding. You should not do both. Talk to your doctor about the best way to feed your baby if you are receiving </span></em>Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Driving and using machines</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">Dizziness and vision problems may occur during treatment with this medicine (see section 4). This should be considered in cases where full alertness is required, e.g., when driving a car or handling machines.</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Abilify Maintena contains sodium"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><span lang="EN-GB">Abilify Maintena contains less than 1 mmol sodium (23 mg) per dose. This means that the medicine is essentially ‘sodium-free’.</span></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">3.       How </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is given</span></em></span></b></p><p class="MsoNormal"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Abilify Maintena comes as a powder which your doctor or nurse will make into a suspension.</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Your doctor will decide on the dose of Abilify Maintena that is right for you. The recommended starting dose is 400 mg unless your doctor decided to give you a lower starting or follow up dose (300 mg, 200 mg or 160 mg).</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none">There are two ways to start Abilify Maintena, your doctor will decide which way is right for you.</p><p class="MsoNormal" style="text-autospace:none"><em><span style="color:black; font-style:normal">•        </span></em>If you are given one injection of Abilify Maintena on your first day the <span lang="EN-GB">treatment with     aripiprazole by mouth is continued for 14 days after the first injection.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span style="color:black;font-style:normal">•        </span></em>If you are given two injections of Abilify Maintena on your first day, you will also take one tablet of aripiprazole by mouth at this visit.</p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">After that, treatment is given with injections of Abilify Maintena unless your doctor tells you otherwise.</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Your doctor will give it to you as a single injection into the gluteal or deltoid muscle (buttock or shoulder) every month. You may feel a little pain during the injection. Your doctor will alternate the injections between your right and left side. The injections will not be given intravenously.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">If you are given more </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">than you should</span></em></span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">This medicine will be given to you under medical supervision; it is therefore unlikely that you will be given too much. If you see more than one doctor, be sure to tell them that you are receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Patients who have been given too much aripiprazole have experienced the following symptoms:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        rapid heartbeat, agitation/aggressiveness, problems with speech.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual movements (especially of the face or tongue) and reduced level of consciousness.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Other symptoms may include:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating,</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        muscle stiffness, and drowsiness or sleepiness, slower breathing, choking, high or low blood pressure, abnormal rhythms of the heart.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Contact your doctor or hospital immediately if you experience any of the above.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">If you miss an injection of </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena</span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">It is important not to miss your scheduled dose. You should be given an injection every month but not before the 26 days has passed from the last injection. If you miss an injection, you should contact your doctor to arrange your next injection as soon as you can.</span></em></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="If you stop receiving Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not stop your treatment just because you feel better. It is important that you carry on receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">for as long as your doctor has told you to.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you have any further questions on the use of this medicine, ask your doctor or nurse.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">4.       Possible side effects</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tell your doctor immediately if you have any of the following serious side effects:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        a combination of any of these symptoms: excessive sleepiness, dizziness, confusion, disorientation, difficulty talking, difficulty walking, muscle stiffness or shaking, fever, weakness, irritability, aggression, anxiety, increase in blood pressure, or seizures that can lead to unconsciousness.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual movement mainly of the face or tongue, since your doctor may want to lower your dose.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        if you have symptoms such as swelling, pain, and redness in the leg, because this may mean you have a blood clot, which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you notice any of these symptoms seek medical advice immediately.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness since this may be a sign of a condition called neuroleptic malignant syndrome (NMS).</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        thirstiness more than usual, need to urinate more than usual, feel very hungry, feel weak or tired, feel sick, feel confused or your breath smells fruity, since this may be a sign of diabetes.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">The side effects listed below may also occur after receiving Abilify Maintena.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="text-autospace:none"><em><span lang="EN-GB" style="color:black">Common side effects (may affect up to 1 in 10 people):</span></em></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        weight gain</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        diabetes mellitus</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        weight loss</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling restless</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling anxious</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">unable to keep still, difficulty sitting still</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">difficulty sleeping (insomnia)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">jerky resistance to passive movement as muscles tense and relax, abnormally increased muscle tone, slow body movement</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">akathisia (an uncomfortable feeling of inner restlessness and a compelling need to move constantly)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">shaking or trembling</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">uncontrollable twitching, jerking or writhing movements</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">changes in your level of alertness, drowsiness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sleepiness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dizziness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">headache</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dry mouth</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle stiffness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">inability to have or maintain an erection during sexual intercourse</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">pain at the injection site, hardening of the skin at the injection site</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">weakness, loss of strength or extreme tiredness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during blood tests your doctor may find higher amounts of creatine phosphokinase in your blood (enzyme important for muscle function)</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Uncommon side effects (may affect up to 1 in 100 people):</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">low level of a specific type of white blood cells (neutropenia), low haemoglobin or red blood cell count, low level of blood platelets</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">allergic reactions (hypersensitivity)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        decreased or </span></em><span lang="EN-GB" style="color:black">increased blood levels of the hormone prolactin</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">high blood sugar</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased blood fats such as high cholesterol, high triglycerides and also low level of cholesterol and low level of triglycerides</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased levels of insulin, a hormone regulating blood sugar levels</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">decreased or increased appetite</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">thoughts about suicide</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">mental disorder characterized by defective or lost contact with reality</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">hallucination</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">delusion</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased sexual interest</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">panic reaction</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">depression</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">affect lability</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">state of indifference with lack of emotion, feelings of emotional and mental discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sleep disorder</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">grinding of teeth or clenching of the jaw</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">reduced sexual interest (libido is decreased)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">altered mood</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle problems</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle movements that you cannot control such as grimacing, lip-smacking and tongue movements. They usually affect the face and mouth first but can affect other parts of the body. These could be signs of a condition called “tardive dyskinesia”.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">parkinsonism - medical condition with many various symptoms which include decreased or slow movements, slowness of thought, jerks when bending the limbs (cogwheel rigidity), shuffling, hurried steps, shaking, little or no facial expression, muscle stiffness, drooling</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">movement problems</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">extreme restlesness and restless legs</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">distortion of the senses of taste and smell</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">fixation of the eyeballs in one position</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">blurred vision</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">eye pain</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">double vision</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span style="color:black;font-style:normal">•        eye sensitivity to light,</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">abnormal heartbeat, slow or fast heart rate, abnormal electrical conduction of the heart, abnormal reading (ECG) of the heart</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">high blood pressure</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dizziness when getting up from a lying or sitting position due to a drop in blood pressure</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">cough</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">hiccups</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">gastroesophageal reflux disease. Excess amount of gastric juice flowing back (refluxes) into the esophagus (gullet or the tube that goes from mouth to stomach through which food passes), causing heartburn and possibly damaging the esophagus</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">heartburn</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">vomiting</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">diarrhoea</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling sick</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">stomach ache</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">stomach discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">constipation</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">frequent bowel movement</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">drooling, more saliva in mouth than normal</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">abnormal hair loss</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">acne, skin condition of the face where the nose and cheeks are unusually red, eczema,skin hardening</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle rigidity, muscle spasms, muscle twitching, muscle tightness, mucle pain (myalgia), pain in extremity</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">joint pain ( arthralgia), back pain, decreased range of motion of joints, stiff neck, limited opening of mouth</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">kidney stones, sugar (glucose) in urine</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">spontaneous flow of milk from the breasts (galactorrhoea)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">enlargement of breast in men, breast tenderness, vaginal dryness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">fever</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">loss of strength</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">gait disturbance</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">chest discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">injection site reactions such as redness, swelling discomfort and injection site itching</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">thirst</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sluggishness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">liver function tests may show abnormal results</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during tests your doctor may find</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of liver enzymes</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of alanine aminotransferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of gamma-glutamyl transferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of bilirubin in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of aspartate aminotransferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher or lower amounts of blood glucose</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of glycosylated haemoglobin</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        lower amounts of cholesterol in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        lower amounts of triglycerides in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        a higher waist circumference</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known (frequency cannot be estimated from the available data):</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        low levels of white blood cells</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        allergic reaction (e.g. swelling in the mouth, tongue, face and throat, itching, hives), rash</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual heartbeat, sudden unexplained death, heart attack</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        diabetic ketoacidosis (ketones in the blood and urine) or coma</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        loss of appetite (anorexia), </span></em><span lang="EN-GB" style="color:black">difficulty in swallowing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        low sodium level in the blood</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        suicide attempt and suicide</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        strong impulse to gamble excessively despite serious personal or family consequences</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        uncontrollable excessive shopping</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        a tendency to wander away</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">Tell your doctor if you experience any of these behaviours; he/she will discuss ways of managing or reducing the symptoms.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        nervousness</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">aggression</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        neuroleptic malignant syndrome ( a syndrome with symptoms such as fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        seizure (fits)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">serotonin syndrome (a reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">speech disorders</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">heart problems including torsades de pointes, stopping of the heart, irregularities in heart rhythm that may be due to abnormal nerve impulses in the heart, abnormal readings during heart examination (ECG) QT prolongation</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        fainting</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">symptoms related to blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        spasm of the muscles around the voice box</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        accidental inhalation of food with risk of pneumonia (lung infection)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        inflammation of the pancreas</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty swallowing</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        liver failure</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        jaundice (yellowing of the skin and white part of eyes)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        inflammation of the liver</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        rash</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><em><span style="color:black;font-style:normal">skin </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">sensitivity to light</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        excessive sweating</span></em></p><p class="MsoNormal" style="margin-left:27.0pt;text-indent:-27.0pt;text-autospace: none">•serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia). </p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle weakness, tenderness or pain and particularly, if at the same time, you feel unwell, have a high temperature or have dark urine. They may be caused by an abnormal muscle breakdown which can be life threatening and lead to kidney problems (a condition called rhabdomyolysis)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty in passing urine</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        involuntary loss of urine (incontinence)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        drug withdrawal symptoms in new-born infant</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        prolonged and/or painful erection</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty controlling core body temperature or overheating</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        chest pain</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        swelling of hands, ankles or feet</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during tests your doctor may find</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts alkaline phosphatase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        fluctuating results during tests to measure glucose in your blood</span></p><p class="MsoNormal"></p><p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Reporting of side effects</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background: silver">the national reporting system listed in </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><u><span style="background:silver">Appendix V</span></u></a>. By reporting side effects, you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="text-align:justify"></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Keep this medicine out of the sight and reach of children.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not use this medicine after the expiry date which is stated on the carton and the vial. The expiry date refers to the last day of that month.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not freeze.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">The reconstituted suspension should be used immediately but may be stored below 25°C for up to 4 hours in the vial. Do not store the reconstituted suspension in the syringe.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">6.       Contents of the pack and other information</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">contains</span></em></span></b></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        The active substance is aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Each vial contains 300 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">After reconstitution each ml of suspension contains 200 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Each vial contains 400 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">After reconstitution each ml of suspension contains 200 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        The other ingredients are</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Powder</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Carmellose sodium, mannitol, sodium dihydrogen phosphate monohydrate, sodium hydroxide</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Solvent</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Water for injections</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">looks like and contents of the pack</span></em></span></b></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">is a powder and solvent for prolonged-release suspension for injection.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">comes as a white to off-white powder in a clear glass vial. Your doctor or nurse will make it into a suspension that will be given as an injection using the vial of solvent for </span></em>Abilify Maintena <em><span style="font-style:normal">that comes as a clear solution in a clear glass vial.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Single pack</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Each single pack containing one vial of powder, 2 ml vial of solvent, one 3 ml luer lock syringe with pre-attached 38 mm (1.5 inch) 21 gauge, hypodermic safety needle with needle protection device, one 3 ml disposable syringe with luer lock tip, one vial adapter and three hypodermic safety needles: one 25 mm (1 inch) 23 gauge, one 38 mm (1.5 inch) 22 gauge and one 51 mm (2 inch) 21 gauge.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Multipack</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Bundle pack of 3 single packs.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Not all pack sizes may be marketed.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Marketing Authorisation Holder</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">Otsuka Pharmaceutical Netherlands B.V.</span></p><p class="MsoNormal"><span lang="EN-GB">Herikerbergweg 292</span></p><p class="MsoNormal"><span lang="EN-GB">1101 CT, Amsterdam</span></p><p class="MsoNormal"><span lang="EN-GB">Netherlands</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Manufacturer</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">H. Lundbeck A/S</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Ottiliavej 9, 2500 Valby</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Denmark</span></em></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width:100.0%;border-collapse:collapse" width="100%"> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">België/Belgique/Belgien</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   S.A./N.V.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél/Tel: +32   2 535 79 79</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Lietuva</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">България</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Export A/S Representative Office</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +359   2 962 4696</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Luxembourg/Luxemburg</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél: +32   2 535 79 79</span></em></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:38.1pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:38.1pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Česká republika</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Česká republika s.r.o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +420   225 275 600</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:38.1pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Magyarország</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hungaria Kft.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +36   1 4369980</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:46.1pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:46.1pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Danmark</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:46.1pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Malta</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Deutschland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma GmbH</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +49   69 1700860</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Nederland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   B.V.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +31   20 697 1901</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Eesti</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Norge</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Ελλάδα</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hellas S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Τηλ: +30   210 610 5036</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Österreich</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Austria GmbH</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +43   1 266 91 08</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">España</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +34   93 208 10 20</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Polska</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Poland Sp. z o. o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel.: +48   22 626 93 00</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">France</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical France SAS</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél: +33   (0)1 47 08 00 00</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Portugal</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Portugal Lda</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +351   21 00 45 900</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Hrvatska</span></b></em></p> <p class="MsoNormal"><span lang="EN-GB" style="color:black">Lundbeck Croatia   d.o.o.</span></p> <p class="MsoNormal"><span lang="EN-GB" style="color:black">Tel.: +385 1 644   82 63</span></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">România</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">Export   A/S</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Reprezentanta   din </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">Romania</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +40   21319 88 26</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Ireland</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck (Ireland) Limited</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +353 1 468 9800</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Slovenija</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck Pharma d.o.o.</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel.: +386 2 229 4500</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Ísland</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><span lang="EN-GB">Vistor hf.</span></p> <p class="MsoNormal" style="page-break-after:avoid"><span lang="EN-GB">Sími: +354   535 7000</span></p> <p class="MsoNormal" style="page-break-after:avoid"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Slovenská republika</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck Slovensko s.r.o.</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +421 2 5341 42 18</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Italia</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical Italy S.r.l</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +39   02 00 63 27 10</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Suomi/Finland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Κύπρος</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hellas A.E</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Τηλ.: +357   22490305</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Sverige</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Latvija</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">United Kingdom</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceuticals (UK) Ltd.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +44   203 747 5300</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr height="0"> <td style="border:none" width="351"></td> <td style="border:none" width="3"></td> <td style="border:none" width="351"></td> <td style="border:none" width="3"></td> </tr> </table><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="This leaflet was last revised in {MM/YYYY}."/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Other sources of information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Detailed information on this medicine is available on the European Medicines Agency web site: </span></em><span lang="EN-GB"><a href="http://www.ema.europa.eu/"><u>http://www.ema.europa.eu</u></a><em><span style="color:black;font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal" style="margin-right:-.1pt"><span lang="EN-GB">---------------------------------------------------------------------------------------------------------------------------</span></p><p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">The following information is intended for healthcare professionals only:</span></em></p><p align="center" class="MsoNormal" style="text-align:center"></p><p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">INSTRUCTIONS FOR HEALTH CARE PROFESSIONALS</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection</span></b></em></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">aripiprazole</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 1: Preparation prior to reconstitution of the powder</span></u></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lay out and confirm that components listed below are provided:</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Abilify Maintena package leaflet and instructions for healthcare professionals.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Vial of powder.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        2 ml vial of solvent.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><b><span lang="EN-GB">          Important:</span></b><span lang="EN-GB"> the solvent vial contains an overfill.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 3 ml luer lock syringe with pre-attached 38 mm (1.5 inch) 21 gauge hypodermic safety needle with needle protection device.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 3 ml disposable syringe with luer lock tip.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One vial adapter.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-        One 25 mm (1 inch) 23 gauge hypodermic safety needle<em><span style="font-style:normal"> with needle protection device.</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 38 mm (1.5 inch) 22 gauge hypodermic safety needle with needle protection device.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 51 mm (2 inch) 21 gauge hypodermic safety needle with needle protection device.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Syringe and needle instructions.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 2: Reconstitution of the powder</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">a)       Remove the solvent and powder vial caps and wipe the tops with a sterile alcohol swab.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">b)      Using the syringe with pre-attached needle, withdraw the pre-determined solvent volume from the vial of the solvent into the syringe.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">300 mg vial:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">Add 1.5 ml solvent to reconstitute the powder.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">400 mg vial:</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">Add 1.9 ml solvent to reconstitute the powder.</span></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">A small amount of residual solvent will remain in the vial following withdrawal. Any excess should be discarded.</span></em></p><p class="MsoNormal" style="text-autospace:none"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:120.55pt"> <td style="width:163.05pt;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="217"> <p align="right" class="MsoNormal" style="text-align:right"></p> </td> <td style="width:49.6pt;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="66"> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal"><img alt="Pic 1" border="0" height="145" id="Bild 2" src="#image0" width="55"/></span></em></p> </td> <td style="width:211.85pt;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="282"> <p class="MsoNormal" style="margin-left:-5.4pt"></p> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB">Water</span></p> <p class="MsoNormal"></p> </td> </tr> </table><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">c)       Slowly inject the solvent into the vial containing the powder.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">d)      Withdraw air to equalise the pressure in the vial by pulling back slightly on the plunger.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><p align="center" class="MsoNormal" style="text-align:center"><a name="_Hlk498354571"><span lang="EN-GB" style="color:black"><img alt="Pic 2" border="0" height="137" id="Bild 3" src="#image1" width="53"/></span></a></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">e)       Subsequently, remove the needle from the vial.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">          Engage the needle safety device by using the one-handed technique.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Gently press the sheath against a flat surface until the needle is firmly engaged in the needle protection sheath.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">          Visually confirm that the needle is fully engaged into the needle protection sheath, and discard.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" width="180"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="93" id="Bild 4" src="#image2" width="148"/></span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" width="161"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="97" id="Bild 5" src="#image3" width="123"/></span></p> </td> </tr> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="180"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" width="180"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="93" id="Bild 4" src="#image4" width="148"/></span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" width="161"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="97" id="Bild 5" src="#image5" width="123"/></span></p> </td> </tr> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="180"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">f)       <u>Shake the vial vigorously for 30 seconds until the suspension appears uniform.</u></span></em></p><p class="MsoNormal" style="margin-left:28.35pt"></p><p align="center" class="MsoNormal" style="text-align:center"><a name="_Hlk498354543"><span lang="EN-GB" style="color:black"><img alt="Pic 4" border="0" height="132" id="Bild 6" src="#image6" width="135"/></span></a></p><p align="center" class="MsoNormal" style="text-align:center"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">g)       Visually inspect the reconstituted suspension for particulate matter and discolouration prior to administration. The reconstituted medicine is a white to off-white, fluid suspension. Do not use if reconstituted suspension contains particulate matter or any discolouration.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">h)      If the injection is not performed immediately after reconstitution, keep the vial below 25 °C for up to 4 hours and shake it vigorously for at least 60 seconds to re-suspend prior to injection.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">i)       Do not store the reconstituted suspension in the syringe.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 3: Preparation prior to injection</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">a)       Remove the cover, but not the adapter from the package.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">b)      Using the vial adapter package to handle the vial adapter, attach the pre-packaged luer lock syringe to the vial adapter.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><p align="center" class="MsoNormal" style="text-align:center"><a name="_Hlk498354528"><span lang="EN-GB"><img border="0" height="133" id="Grafik 11" src="#image7" width="89"/></span></a></p><p class="MsoNormal" style="margin-left:21.0pt;text-indent:-21.0pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">c)       Use the luer lock syringe to remove the vial adapter from the package and discard the vial adapter package. <u>Do not touch the spike tip of the adapter at any time.</u></span></em></p><p class="MsoNormal" style="margin-left:21.0pt;text-indent:-21.0pt"><em><u><span lang="EN-GB" style="color:black;font-style:normal"></span></u></em></p><p align="center" class="MsoNormal" style="text-align:center"><a name="_Hlk498354519"><span lang="EN-GB"><img border="0" height="133" id="Grafik 19" src="#image8" width="70"/></span></a></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">d)      Determine the recommended volume for injection.</span></em></p><p class="MsoNormal"></p><div align="center"> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none" width="288"> <tr> <td colspan="2" style="width:215.65pt;border:solid windowtext 1.0pt;   border-left:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="288"> <p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 300 mg   Vial</span></b></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Dose</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Volume to Inject</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">---</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">---</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">300 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.5 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">200 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">160 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">0.8 ml</span></em></p> </td> </tr> </table> </div><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none" width="288"> <tr> <td colspan="2" style="width:215.65pt;border:solid windowtext 1.0pt;   border-left:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="288"> <p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 300 mg   Vial</span></b></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Dose</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Volume to Inject</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">---</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">---</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">300 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.5 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">200 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">160 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">0.8 ml</span></em></p> </td> </tr> </table><p class="MsoNormal"></p><div align="center"> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none" width="288"> <tr> <td colspan="2" style="width:215.65pt;border:solid windowtext 1.0pt;   border-left:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="288"> <p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 400 mg   Vial</span></b></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Dose</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Volume to Inject</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">400 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">2.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">300 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.5 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">200 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">160 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">0.8 ml</span></em></p> </td> </tr> </table> </div><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none" width="288"> <tr> <td colspan="2" style="width:215.65pt;border:solid windowtext 1.0pt;   border-left:double windowtext 1.5pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="288"> <p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 400 mg   Vial</span></b></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Dose</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">Volume to Inject</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">400 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">2.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">300 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.5 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">200 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">1.0 ml</span></em></p> </td> </tr> <tr> <td style="width:90.05pt;border-top:none;border-left:   double windowtext 1.5pt;border-bottom:solid windowtext 1.0pt;border-right:   solid windowtext 1.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="120"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">160 mg</span></em></p> </td> <td style="width:125.6pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="167"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">0.8 ml</span></em></p> </td> </tr> </table><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">e)       Wipe the top of the vial of the reconstituted suspension with a sterile alcohol swab.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">f)       Place and hold the vial of the reconstituted suspension on a hard surface. Attach the adapter-syringe assembly to the vial by holding the outside of the adapter and pushing the adapter’s spike firmly through the rubber stopper, until the adapter snaps in place.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">g)       Slowly withdraw the recommended volume from the vial into the luer lock syringe to allow for injection.</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal"> <u>A small amount of excess product will remain in the vial.</u></span></em></p><p class="MsoNormal"></p><p align="center" class="MsoNormal" style="text-align:center"><a name="_Hlk498354506"><span lang="EN-GB"><img border="0" height="139" id="Grafik 16" src="#image9" width="58"/></span></a></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 4: Injection procedure</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">a)       Detach the luer lock syringe containing the recommended volume of reconstituted Abilify Maintena suspension from the vial.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">b)      Select one of the following hypodermic safety needles depending on the injection site and patient’s weight and attach the needle to the luer lock syringe containing the suspension for injection. Ensure the needle is firmly seated on the needle protection device with a push and clockwise twist and then pull the needle cap straight away from the needle.</span></em></p><p class="MsoNormal"></p><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse;border:none"> <tr> <td style="width:120.5pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p class="MsoNormal"><b><span lang="EN-GB">Body type</span></b></p> </td> <td style="width:85.05pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Injection site</span></b></p> </td> <td style="width:198.45pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="265"> <p class="MsoNormal"><b><span lang="EN-GB">Needle size</span></b></p> </td> </tr> <tr> <td style="width:120.5pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Non-obese</span></b></p> </td> <td style="width:85.05pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:198.45pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="265"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">25 mm (1 inch) 23 gauge</span></b></p> </td> </tr> <tr> <td style="width:120.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p class="MsoNormal"></p> </td> <td style="width:85.05pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> <td style="width:198.45pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="265"> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch)   22 gauge</span></b></p> </td> </tr> <tr> <td style="width:120.5pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Obese</span></b></p> </td> <td style="width:85.05pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:198.45pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="265"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch)   22 gauge</span></b></p> </td> </tr> <tr> <td style="width:120.5pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p class="MsoNormal"></p> </td> <td style="width:85.05pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> <td style="width:198.45pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="265"> <p class="MsoNormal"><b><span lang="EN-GB">51 mm (2 inch) 21 gauge</span></b></p> </td> </tr> </table><p align="center" class="MsoNormal" style="text-align:center"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">c)       Slowly inject the recommended volume as a single intramuscular injection into the gluteal or deltoid muscle. Do not massage the injection site. Care must be taken to avoid inadvertent injection into the blood vessel. Do not inject into an area with signs of inflammation, skin damage, lumps and/or bruises.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><span lang="EN-GB" style="color:black">For deep intramuscular gluteal or deltoid injection only.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:28.35pt;border-collapse:collapse"> <tr> <td style="width:218.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="291"> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal"><img border="0" height="181" id="Bild 10" src="#image10" width="218"/></span></em></p> </td> <td style="width:218.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="291"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal"><img border="0" height="181" id="Bild 11" src="#image11" width="180"/></span></em></p> </td> </tr> <tr> <td style="width:218.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="291"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">deltoid</span></em></p> </td> <td style="width:218.0pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="291"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">gluteal</span></em></p> </td> </tr> </table><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB" style="color:black">Remember to rotate sites of injections between the two gluteal or deltoid muscles. </span></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB" style="color:black">If initiating with the two injection start, inject into two different sites in two different muscles. </span><span lang="EN-GB">DO NOT inject both injections concomitantly into the same deltoid or gluteal muscle.</span></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB">For known CYP2D6 poor metabolisers administer in either<s> </s>two separate deltoid muscles or one deltoid and one gluteal muscle.</span><span lang="EN-GB">DO NOT inject into two gluteal muscles.</span></p><p class="MsoNormal" style="margin-left:31.5pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Look for signs or symptoms of inadvertent intravenous administration.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 5: Procedures after injection</span></u></em></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Engage the needle safety device as described in Step 2 e). Dispose of the vials, adapter, needles, and syringe appropriately after injection. The powder and solvent vials are for single-use only.</span></p><p class="MsoNormal" style="text-autospace:none"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" width="180"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="93" id="Bild 12" src="#image12" width="148"/></span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" width="161"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="97" id="Bild 13" src="#image13" width="123"/></span></p> </td> </tr> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="180"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" width="180"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="93" id="Bild 12" src="#image14" width="148"/></span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" width="161"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="97" id="Bild 13" src="#image15" width="123"/></span></p> </td> </tr> <tr> <td style="width:134.7pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="180"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:120.45pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="161"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table><p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"></p><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Package leaflet: Information for the user</span></b></em></p><p class="MsoNormal"></p><p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">300 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe</span></em></span></b></p><p align="center" class="MsoNormal" style="text-align:center"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">400 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe</span></em></span></b></p><p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">aripiprazole</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Read all of this leaflet carefully before you receive this medicine because it contains important information for you.</span></b></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Keep this leaflet. You may need to read it again.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        If you have any further questions, ask your doctor or nurse.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. See section 4.</span></em></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What is in this leaflet</span></b></em></p><p class="MsoNormal" style="margin-left:21.3pt;text-indent:-21.3pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">1.       What </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is and what it is used for</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">2.       What you need to know before you are given </span></em><span lang="EN-GB" style="color:black">Abilify Maintena</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">3.       How </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is given</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">4.       Possible side effects</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">5.       How to store </span></em><span lang="EN-GB" style="color:black">Abilify Maintena</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">6.       Contents of the pack and other information</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">1.       What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is and what it is used for</span></em></span></b></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">contains the active substance aripiprazole and belongs to a group of medicines called antipsychotics. It is used to treat schizophrenia - a disease with symptoms such as hearing, seeing or sensing things which are not there, suspiciousness, mistaken beliefs, incoherent speech and behaviour and emotional flatness. People with this condition may also feel depressed, guilty, anxious or tense.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">is intended for adult patients with schizophrenia who are sufficiently stabilised during treatment with oral aripiprazole.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
		
		
    	    
				
			    
						
		               
<section>
			<title value="2.       What you need to know before you are given Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Do not use Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•</span></em><em><span lang="EN-GB" style="color:black;font-style:normal">        if you are allergic to aripiprazole or any of the other ingredients of this medicine (listed in section 6).</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Warnings and precautions</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Talk to your doctor or nurse before you are given </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Suicidal thoughts and behaviours have been reported during aripiprazole treatment. Tell your doctor immediately if you are having any thoughts or feelings about hurting yourself.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Before treatment with </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">, tell your doctor if you suffer from</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        an acutely agitated state or a severely psychotic state</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        heart problems or have a history of stroke, especially if you know that you have other risks factors for stroke</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        high blood sugar (characterised by symptoms such as excessive thirst, passing of large amounts of urine, increase in appetite and feeling weak) or family history of diabetes</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        fits (seizures) since your doctor may want to monitor you more closely</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        involuntary, irregular muscle movements, especially in the face</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">experience a combination of fever, sweating, faster breathing, muscle stiffness and drowsiness or sleepiness (may be signs of neuroleptic malignant syndrome)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dementia (loss of memory and other mental abilities) especially if you are elderly</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        cardiovascular diseases (diseases of the heart and circulation), family history of cardiovascular disease, stroke or "mini" stroke, abnormal blood pressure</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        irregular heart beat or if someone else in your family has a history of irregular heart beat (including so called QT prolongation seen with ECG monitoring).</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        blood clots, or family history of blood clots, as antipsychotics have been associated with formation of blood clots</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">have any difficulty in swallowing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        past experience with excessive gambling</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        severe liver problems.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you notice you are gaining weight, develop unusual movements, experience sleepiness that interferes with normal daily activities, any difficulty in swallowing or have allergic symptoms, please talk to your doctor immediately.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB">Tell your doctor if you or your family/carer notices that you are developing urges or cravings to behave in ways that are unusual for you and you cannot resist the impulse, drive or temptation to carry out certain activities that could harm yourself or others. These are called impulse control disorders and can include behaviours such as addictive gambling, excessive eating or spending, an abnormally high sex drive or preoccupation with an increase in sexual thoughts or feelings.</span></p><p class="MsoNormal"><u><span lang="EN-GB">Your doctor may need to adjust or stop your dose.</span></u></p><p class="MsoNormal"></p><p class="MsoNormal" style="background:white"><span style="color:#212121">Aripiprazole</span><span style="color:#212121"> may cause sleepiness, fall in blood pressure when standing up, dizziness and changes in your ability to move and balance, which may lead to falls. Caution should be taken, particularly if you are an elderly patient or have some debility.</span></p><p class="MsoNormal" style="background:white"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Children and adolescents"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><span lang="EN-GB" style="color:black">Do not use this medicine in children and adolescents under 18 years of age. It is not known if it is safe and effective in these patients.</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Other medicines and Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tell your doctor if you are taking, have recently taken or might take any other medicines.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Blood pressure-lowering medicines:</span></em><span lang="EN-GB" style="color:black"> Abilify Maintena <em><span style="font-style:normal">may increase the effect of medicines used to lower the blood pressure. Be sure to tell your doctor if you take a medicine to keep your blood pressure under control.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">with some medicines may mean the doctor will need to change your dose of </span></em>Abilify Maintena <em><span style="font-style: normal">or the other medicines. It is especially important to mention the following to your doctor:</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        medicines to correct heart rhythm (such as quinidine, amiodarone, flecainide)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        antidepressants or herbal remedy used to treat depression and anxiety</span></em><span class="berschrift4Zchn"></span><span class="berschrift4Zchn"><span lang="EN-GB" style='font-family:"Times New Roman",serif;color:black;font-weight:normal'>(</span></span><em><span lang="EN-GB" style="color:black;font-style:normal">such as fluoxetine, paroxetine, St. John's Wort)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        antifungal medicines (such as ketoconazole, itraconazole)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        certain medicines to treat HIV infection (such as efavirenz, nevirapine, and protease inhibitors e.g. indinavir, ritonavir)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        anticonvulsants used to treat epilepsy (such as </span></em><span class="BMSHeading3Char"><span lang="EN-GB" style='font-family:"Times New Roman",serif;font-weight:normal'>carbamazepine, phenytoin,</span></span><span class="BMSHeading3Char"></span><em><span lang="EN-GB" style="color:black;font-style:normal">phenobarbital)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        certain antibiotics used to treat tuberculosis (rifabutin, rifampicin)</span></em></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        medicines that are known to prolong QT prolongation.</span></em></p><p class="EMEABodyText"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt">These medicines may increase the risk of side effects or reduce the effect of <span style="color:black">Abilify Maintena</span>; if you get any unusual symptom taking any of these medicines together with <span style="color:black">Abilify Maintena</span>, you should see your doctor.</span></p><p class="EMEABodyText"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt;color:black">Medicines that increase the level of serotonin </span><span class="BMSHeading3Char"><span lang="EN-GB" style='font-size:11.0pt;font-family:"Times New Roman",serif; font-weight:normal'>are typically used in conditions including depression, generalised anxiety disorder, obsessive-compulsive disorder (OCD) and social phobia as well as migraine and pain</span></span><span lang="EN-GB" style="font-size:11.0pt; color:black">:</span></p><p class="EMEABodyText"></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt">triptans, tramadol and tryptophan used for conditions including depression, generalised anxiety disorder, obsessive compulsive disorder (OCD) and social phobia as well as migraine and pain</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">SSRI s (such as paroxetine and fluoxetine) used for depression, OCD, panic and anxiety</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">other anti-depressants (such as venlafaxine and tryptophan) used in major depression</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">tricyclic’s (such as clomipramine and amitriptyline) used for depressive illness</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">St John’s Wort (<i>Hypericum perforatum</i>) used as a herbal remedy for mild depression</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">painkillers (such as tramadol and pethidine) used for pain relief</span></p><p class="EMEABodyText" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black">triptans (such as sumatriptan and zolmitripitan) used for treating migraine.</span></p><p class="MsoNormal"></p><p class="EMEABodyText"><span lang="EN-GB" style="font-size:11.0pt">These medicines may increase the risk of side effects; if you get any unusual symptom taking any of these medicines together with <span style="color:black">Abilify Maintena</span>, you should see your doctor.</span></p><p class="EMEABodyText"></p><p class="MsoNormal"><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">with alcohol</span></em></span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Alcohol should be avoided.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Pregnancy, breast-feeding and fertility</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before receiving this medicine.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">You should not be given </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">if you are pregnant unless you have</span></em></span></b><em><span lang="EN-GB" style="color:black;font-style: normal"> discussed this with your doctor. </span></em><span lang="EN-GB" style="color:black">Be sure to tell your doctor immediately if you are pregnant, think you may be pregnant, or if you are planning to become pregnant.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">The following symptoms may occur in new-born babies, of mothers that have received </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">in the last trimester (last three months of their pregnancy):</span></em></span></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If your baby develops any of these symptoms you need to contact your doctor.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you are receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">, your doctor will discuss with you whether you should breast-feed considering the benefit to you of your therapy and the benefit to your baby of breast-feeding. You should not do both. Talk to your doctor about the best way to feed your baby if you are receiving </span></em>Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Driving and using machines</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">Dizziness and vision problems may occur during treatment with this medicine (see section 4). This should be considered in cases where full alertness is required, e.g., when driving a car or handling machines.</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    

			    
		               
<section>
			<title value="Abilify Maintena contains sodium"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><span lang="EN-GB">Abilify Maintena contains less than 1 mmol sodium (23 mg) per dose. This means that the medicine is essentially ‘sodium-free’.</span></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">3.       How </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style: normal">is given</span></em></span></b></p><p class="MsoNormal"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Abilify Maintena comes as a pre‑filled syringe.</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Your doctor will decide on the dose of Abilify Maintena that is right for you. The recommended starting dose is 400 mg unless your doctor decided to give you a lower starting or follow up dose (300 mg, 200 mg or 160 mg).</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none">There are two ways to start Abilify Maintena, your doctor will decide which way is right for you.</p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span style="color:black;font-style:normal">•        </span></em><em><span style="color:black;font-style:normal">If you are given one injection of Abilify Maintena on your first day the </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">treatment with aripiprazole by </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">mouth</span></em><em><span lang="EN-GB" style="color:black;font-style:normal"> is continued for 14 days after the first injection.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">If you are given two injections of Abilify Maintena on your first day, you will also take one tablet of aripiprazole by mouth at this visit.</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">After that, treatment is given with injections of Abilify Maintena unless your doctor tells you otherwise.</span></p><p class="MsoNormal"></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">Your doctor will give it to you as a single injection into the gluteal or deltoid muscle (buttock or shoulder) every month. You may feel a little pain during the injection. Your doctor will alternate the injections between your right and left side. The injections will not be given intravenously.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">If you are given more </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">than you should</span></em></span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">This medicine will be given to you under medical supervision; it is therefore unlikely that you will be given too much. If you see more than one doctor, be sure to tell them that you are receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena<em><span style="font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Patients who have been given too much aripiprazole have experienced the following symptoms:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        rapid heartbeat, agitation/aggressiveness, problems with speech.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual movements (especially of the face or tongue) and reduced level of consciousness.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Other symptoms may include:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        acute confusion, seizures (epilepsy), coma, a combination of fever, faster breathing, sweating,</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        muscle stiffness, and drowsiness or sleepiness, slower breathing, choking, high or low blood pressure, abnormal rhythms of the heart.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Contact your doctor or hospital immediately if you experience any of the above.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">If you miss an injection of </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena</span></b></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">It is important not to miss your scheduled dose. You should be given an injection every month but not before the 26 days has passed from the last injection. If you miss an injection, you should contact your doctor to arrange your next injection as soon as you can.</span></em></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="If you stop receiving Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not stop your treatment just because you feel better. It is important that you carry on receiving </span></em><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">for as long as your doctor has told you to.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">If you have any further questions on the use of this medicine, ask your doctor or nurse.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">4.       Possible side effects</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Like all medicines, this medicine can cause side effects, although not everybody gets them.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tell your doctor immediately if you have any of the following serious side effects:</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        a combination of any of these symptoms: excessive sleepiness, dizziness, confusion, disorientation, difficulty talking, difficulty walking, muscle stiffness or shaking, fever, weakness, irritability, aggression, anxiety, increase in blood pressure, or seizures that can lead to unconsciousness.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual movement mainly of the face or tongue, since your doctor may want to lower your dose.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        if you have symptoms such as swelling, pain, and redness in the leg, because this may mean you have a blood clot, which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing. If you notice any of these symptoms seek medical advice immediately.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        a combination of fever, faster breathing, sweating, muscle stiffness and drowsiness or sleepiness since this may be a sign of a condition called neuroleptic malignant syndrome (NMS).</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        thirstiness more than usual, need to urinate more than usual, feel very hungry, feel weak or tired, feel sick, feel confused or your breath smells fruity, since this may be a sign of diabetes.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">The side effects listed below may also occur after receiving Abilify Maintena.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="page-break-after:avoid;text-autospace:none"><em><span lang="EN-GB" style="color:black">Common side effects (may affect up to 1 in 10 people):</span></em></p><p class="MsoNormal" style="page-break-after:avoid;text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        weight gain</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        diabetes mellitus</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        weight loss</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling restless</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling anxious</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">unable to keep still, difficulty sitting still</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">difficulty sleeping (insomnia)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">jerky resistance to passive movement as muscles tense and relax, abnormally increased muscle tone, slow body movement</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">akathisia (an uncomfortable feeling of inner restlessness and a compelling need to move constantly)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">shaking or trembling</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">uncontrollable twitching, jerking or writhing movements</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">changes in your level of alertness, drowsiness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sleepiness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dizziness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">headache</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dry mouth</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle stiffness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">inability to have or maintain an erection during sexual intercourse</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">pain at the injection site, hardening of the skin at the injection site</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">weakness, loss of strength or extreme tiredness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during blood tests your doctor may find higher amounts of creatine phosphokinase in your blood (enzyme important for muscle function)</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Uncommon side effects (may affect up to 1 in 100 people):</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">low level of a specific type of white blood cells (neutropenia), low haemoglobin or red blood cell count, low level of blood platelets</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">allergic reactions (hypersensitivity)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        decreased or </span></em><span lang="EN-GB" style="color:black">increased blood levels of the hormone prolactin</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">high blood sugar</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased blood fats such as high cholesterol, high triglycerides and also low level of cholesterol and low level of triglycerides</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased levels of insulin, a hormone regulating blood sugar levels</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">decreased or increased appetite</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">thoughts about suicide</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">mental disorder characterized by defective or lost contact with reality</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">hallucination</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">delusion</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">increased sexual interest</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">panic reaction</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">depression</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">affect lability</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">state of indifference with lack of emotion, feelings of emotional and mental discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sleep disorder</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">grinding of teeth or clenching of the jaw</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">reduced sexual interest (libido is decreased)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">altered mood</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle problems</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle movements that you cannot control such as grimacing, lip-smacking and tongue movements. They usually affect the face and mouth first but can affect other parts of the body. These could be signs of a condition called “tardive dyskinesia”.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">parkinsonism - medical condition with many various symptoms which include decreased or slow movements, slowness of thought, jerks when bending the limbs (cogwheel rigidity), shuffling, hurried steps, shaking, little or no facial expression, muscle stiffness, drooling</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">movement problems</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">extreme restlesness and restless legs</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">distortion of the senses of taste and smell</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">fixation of the eyeballs in one position</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">blurred vision</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">eye pain</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">double vision</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span style="color:black;font-style:normal">•        eye sensitivity to light,</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">abnormal heartbeat, slow or fast heart rate, abnormal electrical conduction of the heart, abnormal reading (ECG) of the heart</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">high blood pressure</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">dizziness when getting up from a lying or sitting position due to a drop in blood pressure</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">cough</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">hiccups</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">gastroesophageal reflux disease. Excess amount of gastric juice flowing back (refluxes) into the esophagus (gullet or the tube that goes from mouth to stomach through which food passes), causing heartburn and possibly damaging the esophagus</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">heartburn</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">vomiting</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">diarrhoea</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">feeling sick</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">stomach ache</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">stomach discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">constipation</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">frequent bowel movement</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">drooling, more saliva in mouth than normal</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">abnormal hair loss</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">acne, skin condition of the face where the nose and cheeks are unusually red, eczema,skin hardening</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle rigidity, muscle spasms, muscle twitching, muscle tightness, mucle pain (myalgia), pain in extremity</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">joint pain ( arthralgia), back pain, decreased range of motion of joints, stiff neck, limited opening of mouth</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">kidney stones, sugar (glucose) in urine</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">spontaneous flow of milk from the breasts (galactorrhoea)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">enlargement of breast in men, breast tenderness, vaginal dryness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">fever</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">loss of strength</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">gait disturbance</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">chest discomfort</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">injection site reactions such as redness, swelling discomfort and injection site itching</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">thirst</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">sluggishness</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">liver function tests may show abnormal results</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during tests your doctor may find</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of liver enzymes</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of alanine aminotransferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of gamma-glutamyl transferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of bilirubin in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of aspartate aminotransferase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher or lower amounts of blood glucose</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts of glycosylated haemoglobin</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        lower amounts of cholesterol in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        lower amounts of triglycerides in your blood</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        a higher waist circumference</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">The following side effects have been reported since the marketing of oral aripiprazole but the frequency for them to occur is not known (frequency cannot be estimated from the available data):</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        low levels of white blood cells</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        allergic reaction (e.g. swelling in the mouth, tongue, face and throat, itching, hives), rash</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        unusual heartbeat, sudden unexplained death, heart attack</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        diabetic ketoacidosis (ketones in the blood and urine) or coma</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        loss of appetite (anorexia), </span></em><span lang="EN-GB" style="color:black">difficulty in swallowing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        low sodium level in the blood</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        suicide attempt and suicide</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">inability to resist the impulse, drive or temptation to perform an action that could be harmful to you or others, which may include:</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        strong impulse to gamble excessively despite serious personal or family consequences</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        altered or increased sexual interest and behaviour of significant concern to you or to others, for example, an increased sexual drive</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        uncontrollable excessive shopping</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        binge eating (eating large amounts of food in a short time period) or compulsive eating (eating more food than normal and more than is needed to satisfy your hunger)</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB">-        a tendency to wander away</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-autospace:none"><span lang="EN-GB">Tell your doctor if you experience any of these behaviours; he/she will discuss ways of managing or reducing the symptoms.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        nervousness</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">aggression</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        neuroleptic malignant syndrome ( a syndrome with symptoms such as fever, muscle stiffness, faster breathing, sweating, reduced consciousness and sudden changes in blood pressure and heart rate)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        seizure (fits)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">serotonin syndrome (a reaction which may cause feelings of great happiness, drowsiness, clumsiness, restlessness, feeling of being drunk, fever, sweating or rigid muscles)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB">speech disorders</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">heart problems including torsades de pointes, stopping of the heart, irregularities in heart rhythm that may be due to abnormal nerve impulses in the heart, abnormal readings during heart examination (ECG) QT prolongation</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        fainting</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">symptoms related to blood clots in the veins especially in the legs (symptoms include swelling, pain and redness in the leg), which may travel through blood vessels to the lungs causing chest pain and difficulty in breathing</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        spasm of the muscles around the voice box</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        accidental inhalation of food with risk of pneumonia (lung infection)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        inflammation of the pancreas</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty swallowing</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        liver failure</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        jaundice (yellowing of the skin and white part of eyes)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        inflammation of the liver</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        rash</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><em><span style="color:black;font-style:normal">skin </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">sensitivity to light</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        excessive sweating</span></em></p><p class="MsoNormal" style="margin-left:27.0pt;text-indent:-27.0pt;text-autospace: none">•serious allergic reactions such as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). DRESS appears initially as flu-like symptoms with a rash on the face and then with an extended rash, high temperature, enlarged lymph nodes, increased levels of liver enzymes seen in blood tests and an increase in a type of white blood cell (eosinophilia). </p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">muscle weakness, tenderness or pain and particularly, if at the same time, you feel unwell, have a high temperature or have dark urine. They may be caused by an abnormal muscle breakdown which can be life threatening and lead to kidney problems (a condition called rhabdomyolysis)</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty in passing urine</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        involuntary loss of urine (incontinence)</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        drug withdrawal symptoms in new-born infant</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        prolonged and/or painful erection</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        difficulty controlling core body temperature or overheating</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        chest pain</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">•        swelling of hands, ankles or feet</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><em><span lang="EN-GB" style="color:black;font-style:normal">•        </span></em><span lang="EN-GB" style="color:black">during tests your doctor may find</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        higher amounts alkaline phosphatase</span></p><p class="MsoNormal" style="margin-left:56.7pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">-        fluctuating results during tests to measure glucose in your blood</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Reporting of side effects</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via <span style="background: silver">the national reporting system listed in </span><a href="http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_form/2013/03/WC500139752.doc"><u><span style="background:silver">Appendix V</span></u></a>. By reporting side effects, you can help provide more information on the safety of this medicine.</span></p><p class="MsoNormal" style="text-align:justify"></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
				
			    
						
		               
<section>
			<title value="5.       How to store Abilify Maintena"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Keep this medicine out of the sight and reach of children.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not use this medicine after the expiry date which is stated on the carton and the pre-filled syringe. The expiry date refers to the last day of that month.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Do not freeze.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB">Keep the pre‑filled syringe in the outer carton in order to protect from light.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB">If the injection is not performed immediately after reconstitution, the syringe can be kept <em><span style="font-style:normal">below 25 °C </span></em>for up to 2 hours.</span></p><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><b><span lang="EN-GB" style="color:black;font-style:normal">6.       Contents of the pack and other information</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">contains</span></em></span></b></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        The active substance is aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Each pre‑filled syringe contains 300 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">After reconstitution each ml of suspension contains 200 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Each pre‑filled syringe contains 400 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">After reconstitution each ml of suspension contains 200 mg aripiprazole.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        The other ingredients are</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Powder</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Carmellose sodium, mannitol, sodium dihydrogen phosphate monohydrate, sodium hydroxide</span></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Solvent</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Water for injections</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">What </span></b></em><b><span lang="EN-GB" style="color:black">Abilify Maintena <em><span style="font-style:normal">looks like and contents of the pack</span></em></span></b></p><p class="MsoNormal"><span lang="EN-GB">Abilify Maintena <em><span style="font-style:normal">comes in a pre‑filled syringe containing a white to off-white powder in the front chamber and a clear solvent in the rear chamber. Your doctor will make it into a suspension that will be given as an injection.</span></em></span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Single pack</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Each single pack containing one pre‑filled syringe and three hypodermic safety needles: one 25 mm (1 inch) 23 gauge, one 38 mm (1.5 inch) 22 gauge and one 51 mm (2 inch) 21 gauge.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black">Multipack</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Bundle pack of 3 single packs.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Not all pack sizes may be marketed.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Marketing Authorisation Holder</span></b></em></p><p class="MsoNormal"><span lang="EN-GB">Otsuka Pharmaceutical Netherlands B.V.</span></p><p class="MsoNormal"><span lang="EN-GB">Herikerbergweg 292</span></p><p class="MsoNormal"><span lang="EN-GB">1101 CT, Amsterdam</span></p><p class="MsoNormal"><span lang="EN-GB">Netherlands</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Manufacturer</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">H. Lundbeck A/S</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Ottiliavej 9, 2500 Valby</span></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Denmark</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><span lang="EN-GB" style="background:silver">Elaiapharm</span></p><p class="MsoNormal"><span lang="EN-GB" style="background:silver">2881 Route des Crêtes Z.I Les Bouillides Sophia Antipolis</span></p><p class="MsoNormal"><span lang="EN-GB" style="background:silver">06550 Valbonne</span></p><p class="MsoNormal"><span lang="EN-GB" style="background:silver">France</span></p><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width:100.0%;border-collapse:collapse" width="100%"> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">België/Belgique/Belgien</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   S.A./N.V.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél/Tel: +32   2 535 79 79</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Lietuva</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">България</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Export A/S Representative Office</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +359   2 962 4696</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Luxembourg/Luxemburg</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél: +32   2 535 79 79</span></em></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:38.1pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:38.1pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Česká republika</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Česká republika s.r.o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +420   225 275 600</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:38.1pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Magyarország</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hungaria Kft.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +36   1 4369980</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:46.1pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:46.1pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Danmark</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:46.1pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Malta</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Deutschland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma GmbH</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +49   69 1700860</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Nederland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   B.V.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +31   20 697 1901</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Eesti</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Norge</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td style="width:49.64%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="49%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Ελλάδα</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hellas S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Τηλ: +30   210 610 5036</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Österreich</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Austria GmbH</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +43   1 266 91 08</span></em></p> <p class="MsoNormal"></p> </td> <td style="border:none;padding:0in 0in 0in 0in" width="2"><p class="MsoNormal"> </p></td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">España</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical S.A.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +34   93 208 10 20</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Polska</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Poland Sp. z o. o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel.: +48   22 626 93 00</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">France</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical France SAS</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tél: +33   (0)1 47 08 00 00</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Portugal</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Portugal Lda</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +351   21 00 45 900</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Hrvatska</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><span lang="EN-GB" style="color:black">Lundbeck Croatia d.o.o.</span></p> <p class="MsoNormal" style="page-break-after:avoid"><span lang="EN-GB" style="color:black">Tel.: +385 1 644 82 63</span></p> <p class="MsoNormal" style="page-break-after:avoid"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal" style="page-break-after:avoid"><em><b><span lang="EN-GB" style="color:black;font-style:normal">România</span></b></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">Export A/S</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Reprezentanta din </span></em><em><span lang="EN-GB" style="color:black;font-style:normal">Romania</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +40 21319 88 26</span></em></p> <p class="MsoNormal" style="page-break-after:avoid"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Ireland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   (Ireland) Limited</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +353   1 468 9800</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Slovenija</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Pharma d.o.o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel.: +386   2 229 4500</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Ísland</span></b></em></p> <p class="MsoNormal"><span lang="EN-GB">Vistor hf.</span></p> <p class="MsoNormal"><span lang="EN-GB">Sími: +354 535 7000</span></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Slovenská republika</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Slovensko s.r.o.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +421   2 5341 42 18</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Italia</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceutical Italy S.r.l</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +39   02 00 63 27 10</span></em></p> <p class="MsoNormal"></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Suomi/Finland</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Κύπρος</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lundbeck   Hellas A.E</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Τηλ.: +357   22490305</span></em></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Sverige</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharma Scandinavia AB</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +46   8 54528660</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr style="height:6.85pt"> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">Latvija</span></b></em></p> <p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB">H. Lundbeck   A/S</span></p> <p class="MsoNormal"><span lang="EN-GB">Tel: +45 36301311</span></p> </td> <td colspan="2" style="width:50.0%;padding:0in 5.4pt 0in 5.4pt;   height:6.85pt" valign="top" width="50%"> <p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:   normal">United Kingdom</span></b></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Otsuka   Pharmaceuticals (UK) Ltd.</span></em></p> <p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Tel: +44   203 747 5300</span></em></p> <p class="MsoNormal"></p> </td> </tr> <tr height="0"> <td style="border:none" width="351"></td> <td style="border:none" width="3"></td> <td style="border:none" width="351"></td> <td style="border:none" width="3"></td> </tr> </table><p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="This leaflet was last revised in {MM/YYYY}."/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p>
			</div>
		</text>
		
    	    

			    
		               
<section>
			<title value="Other sources of information"/>
				<code>
					<coding>
						<system value="http://spor.ema.europa.eu/v1/example-sections"/>
						<code value="${document[n].section[n].subsection[n].typeCode}"/>
						<display value="${document[n].section[n].subsection[n].typeDisplay}"/>
					</coding>
				</code>
		<text>
			<status value="additional"/>
			<div xmlns="http://www.w3.org/1999/xhtml">
		    <p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Detailed information on this medicine is available on the European Medicines Agency web site: </span></em><span lang="EN-GB"><a href="http://www.ema.europa.eu/"><u>http://www.ema.europa.eu</u></a><em><span style="color:black;font-style:normal">.</span></em></span></p><p class="MsoNormal"></p><em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span></em><span lang="EN-GB" style="font-size:11.0pt;color:black;font-style:normal"><br clear="all" style="page-break-before:always"/> </span><br clear="all" style="page-break-before:always"/><p class="MsoNormal" style="margin-right:-.1pt"><span lang="EN-GB">---------------------------------------------------------------------------------------------------------------------------</span></p><p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">The following information is intended for healthcare professionals only:</span></em></p><p align="center" class="MsoNormal" style="text-align:center"></p><p align="center" class="MsoNormal" style="text-align:center"><em><b><span lang="EN-GB" style="color:black;font-style:normal">INSTRUCTIONS FOR HEALTH CARE PROFESSIONALS</span></b></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Any unused medicinal product or waste material should be disposed of in accordance with local requirements.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe</span></b></em></p><p class="MsoNormal"><em><b><span lang="EN-GB" style="color:black;font-style:normal">Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection in pre‑filled syringe</span></b></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">aripiprazole</span></em></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:.5in;text-indent:-.5in"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 1: Preparation prior to reconstitution of the powder</span></u></em></p><p class="MsoNormal"><em><span lang="EN-GB" style="color:black;font-style:normal">Lay out and confirm that components listed below are provided:</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Abilify Maintena package leaflet and instructions for healthcare professionals.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One Abilify Maintena pre‑filled syringe.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB">-        One 25 mm (1 inch) 23 gauge hypodermic safety needle<em><span style="font-style:normal"> with needle protection device.</span></em></span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 38 mm (1.5 inch) 22 gauge hypodermic safety needle with needle protection device.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        One 51 mm (2 inch) 21 gauge hypodermic safety needle with needle protection device.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">-        Syringe and needle instructions.</span></em></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 2: Reconstitution of the powder</span></u></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">a)       Push plunger rod slightly to engage threads. And then, rotate plunger rod until the rod stops rotating to release diluent. After plunger rod is at complete stop, middle stopper will be at the indicator line.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:90.7pt"> <td rowspan="2" style="width:92.15pt;padding:0in 5.4pt 0in 5.4pt;   height:90.7pt" valign="top" width="123"> <p class="MsoNormal"></p> </td> <td rowspan="2" style="width:59.4pt;padding:0in 5.4pt 0in 5.4pt;   height:90.7pt" valign="top" width="79"> <p align="right" class="MsoNormal" style="text-align:right"><span lang="EN-GB" style="color:black"><img border="0" height="177" id="Picture 10" src="#image16" width="73"/></span></p> </td> <td style="width:70.2pt;padding:0in 5.4pt 0in 5.4pt;   height:90.7pt" valign="top" width="94"> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"></p> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"></p> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"></p> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"></p> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"></p> <p align="right" class="MsoNormal" style="text-align:right"><span lang="EN-GB" style="color:black">Indicator line</span></p> </td> <td rowspan="2" style="width:49.1pt;padding:0in 5.4pt 0in 5.4pt;   height:90.7pt" valign="top" width="65"> <p class="MsoNormal" style="margin-left:-5.4pt;text-align:justify"><span lang="EN-GB" style="color:black"><img border="0" height="177" src="#image17" width="57"/></span></p> </td> <td rowspan="2" style="width:153.65pt;padding:0in 5.4pt 0in 5.4pt;   height:90.7pt" valign="top" width="205"> <p class="MsoNormal"></p> </td> </tr> <tr style="height:31.2pt"> <td style="width:70.2pt;padding:0in 5.4pt 0in 5.4pt;   height:31.2pt" valign="top" width="94"> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB">Plunger Rod</span></p> </td> </tr> </table><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">b)      Vertically shake the syringe vigorously for 20 seconds until the reconstituted suspension appears uniform<em><span style="font-style:normal">. The suspension should be injected immediately after reconstitution.</span></em></span></p><p class="MsoNormal"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:67.65pt"> <td rowspan="2" style="width:78.0pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="104"> <p class="MsoNormal"></p> </td> <td style="width:70.85pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="94"> <p align="right" class="MsoNormal" style="margin-left:-5.4pt;text-align:right"><span lang="EN-GB" style="color:black"><img border="0" height="95" id="Picture 14" src="#image18" width="77"/></span></p> </td> <td rowspan="2" style="width:106.3pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="142"> <p class="MsoNormal" style="text-align:justify"><span lang="EN-GB" style="color:black"><img border="0" height="176" src="#image19" width="132"/></span></p> </td> <td rowspan="2" style="width:169.35pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="226"> <p class="MsoNormal"></p> <p class="MsoNormal"></p> <p class="MsoNormal"><span lang="EN-GB">uniform</span></p> <p class="MsoNormal"><span lang="EN-GB">milky white</span></p> <p class="MsoNormal"></p> </td> </tr> <tr> <td style="width:70.85pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="94"> <p align="right" class="MsoNormal" style="text-align:right"><b><span lang="EN-GB">20 seconds</span></b></p> </td> </tr> </table><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">c)       Visually inspect the syringe for particulate matter and discoloration prior to administration. The reconstituted product suspension should appear to be a uniform, homogeneous suspension that is opaque and milky-white in colour.</span></p><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="color:black">d)      If the injection is not performed immediately after reconstitution, the syringe can be kept below 25 °C for up to 2 hours. Shake the syringe vigorously for at least 20 seconds to re-suspend prior to injection if the syringe has been left for more than 15 minutes.</span></p><p class="MsoNormal"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 3: Injection procedure</span></u></em></p><p class="Default" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="font-size:11.0pt">a)       Twist and pull off Over-cap and Tip-cap.</span></p><p class="MsoNormal" style="text-autospace:none"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:67.65pt"> <td rowspan="2" style="width:92.15pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="123"> <p class="MsoNormal"></p> </td> <td rowspan="2" style="width:56.7pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="76"> <p align="right" class="MsoNormal" style="text-align:right"><span lang="EN-GB"><img border="0" height="210" id="Picture 17" src="#image20" width="64"/></span></p> </td> <td style="width:70.9pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="95"> <p class="MsoNormal" style="margin-left:-5.4pt"></p> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB">Twist +</span></p> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB">Pull Off</span></p> <p class="MsoNormal" style="margin-left:-5.4pt"></p> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB">Over-cap</span></p> </td> <td rowspan="2" style="width:49.6pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="66"> <p class="MsoNormal" style="text-align:justify"><span lang="EN-GB"><img border="0" height="210" src="#image21" width="61"/></span></p> </td> <td style="width:155.15pt;padding:0in 5.4pt 0in 5.4pt;   height:67.65pt" valign="top" width="207"> <p class="MsoNormal"></p> </td> </tr> <tr> <td style="width:70.9pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="95"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Tip-cap</span></p> <p align="center" class="MsoNormal" style="text-align:center"></p> </td> <td style="width:155.15pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="207"> <p class="MsoNormal"><span lang="EN-GB">Twist + Pull Off</span></p> <p class="MsoNormal"></p> </td> </tr> </table><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">b)      Select one of the following hypodermic safety needles depending on the injection site and patient’s weight.</span></em></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><div align="center"> <table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"><b><span lang="EN-GB">Body type</span></b></p> </td> <td style="width:84.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Injection site</span></b></p> </td> <td style="width:184.85pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">Needle size</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Non-obese</span></b></p> </td> <td style="width:84.5pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:184.85pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">25 mm (1 inch) 23 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> </td> <td style="width:84.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> </td> <td style="width:184.85pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch) 22 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Obese</span></b></p> </td> <td style="width:84.5pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:184.85pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch)   22 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> </td> <td style="width:84.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> </td> <td style="width:184.85pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">51 mm (2 inch) 21 gauge</span></b></p> </td> </tr> </table> </div><table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse;border:none"> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"><b><span lang="EN-GB">Body type</span></b></p> </td> <td style="width:84.5pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Injection site</span></b></p> </td> <td style="width:184.85pt;border:solid windowtext 1.0pt;   border-left:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">Needle size</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Non-obese</span></b></p> </td> <td style="width:84.5pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:184.85pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">25 mm (1 inch) 23 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> </td> <td style="width:84.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> </td> <td style="width:184.85pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch) 22 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border-top:none;border-left:   solid windowtext 1.0pt;border-bottom:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Obese</span></b></p> </td> <td style="width:84.5pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">Deltoid</span></b></p> </td> <td style="width:184.85pt;border:none;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"></p> <p class="MsoNormal"><b><span lang="EN-GB">38 mm (1.5 inch)   22 gauge</span></b></p> </td> </tr> <tr> <td style="width:131.75pt;border:solid windowtext 1.0pt;   border-top:none;padding:0in 5.4pt 0in 5.4pt" valign="top" width="176"> <p class="MsoNormal"></p> </td> <td style="width:84.5pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="113"> <p class="MsoNormal"><b><span lang="EN-GB">Gluteal</span></b></p> </td> <td style="width:184.85pt;border-top:none;border-left:   none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;   padding:0in 5.4pt 0in 5.4pt" valign="top" width="246"> <p class="MsoNormal"><b><span lang="EN-GB">51 mm (2 inch) 21 gauge</span></b></p> </td> </tr> </table><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">c)       While holding the needle cap, ensure the needle is firmly seated on the safety device with a push. Twist clockwise until snugly fitted.</span></p><p class="MsoNormal" style="text-autospace:none"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:120.55pt"> <td style="width:163.05pt;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="217"> <p align="right" class="MsoNormal" style="text-align:right"></p> </td> <td style="width:85.05pt;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="113"> <p class="MsoNormal"><span lang="EN-GB" style="color:black"><img border="0" height="157" id="Picture 21" src="#image22" width="108"/></span></p> </td> <td style="width:2.45in;padding:0in 5.4pt 0in 5.4pt;   height:120.55pt" valign="top" width="235"> <p class="MsoNormal" style="margin-left:-5.4pt"></p> <p class="MsoNormal" style="margin-left:-5.4pt"></p> <p class="MsoNormal"><span lang="EN-GB">Needle cap</span></p> </td> </tr> </table><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt;text-autospace: none"><span lang="EN-GB" style="color:black">d)      Then <b>pull </b>needle-cap straight up.</span></p><p class="MsoNormal" style="text-autospace:none"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:106.35pt"> <td style="width:163.05pt;padding:0in 5.4pt 0in 5.4pt;   height:106.35pt" valign="top" width="217"> <p align="right" class="MsoNormal" style="text-align:right"></p> <p align="right" class="MsoNormal" style="text-align:right"></p> <p align="right" class="MsoNormal" style="text-align:right"><span lang="EN-GB">Needle   cap</span></p> </td> <td style="width:70.85pt;padding:0in 5.4pt 0in 5.4pt;   height:106.35pt" valign="top" width="94"> <p class="MsoNormal" style="margin-left:-5.4pt"><span lang="EN-GB" style="color:black"><img border="0" height="148" id="Picture 24" src="#image23" width="89"/></span></p> </td> <td style="width:190.6pt;padding:0in 5.4pt 0in 5.4pt;   height:106.35pt" valign="top" width="254"> <p class="MsoNormal"></p> <p class="MsoNormal"></p> <p class="MsoNormal"><span lang="EN-GB">Pull</span></p> <p class="MsoNormal"></p> </td> </tr> </table><p class="MsoNormal" style="text-autospace:none"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><span lang="EN-GB" style="color:black">e)       Hold syringe <b>upright and advance plunger rod slowly to expel the air</b>. If it's not possible to advance plunger rod to expel the air, check that plunger rod is rotated to a complete stop. It is not possible to re-suspend after the air in the syringe is expelled.</span></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse" width="566"> <tr style="height:107.65pt"> <td style="width:163.05pt;padding:0in 5.4pt 0in 5.4pt;   height:107.65pt" valign="bottom" width="217"> <p align="right" class="MsoNormal" style="text-align:right"><b><span lang="EN-GB">*If   there’s resistance or difficulty expelling air,</span></b><span lang="EN-GB">   check that plunger rod is rotated to a complete stop.</span></p> </td> <td style="width:70.85pt;padding:0in 5.4pt 0in 5.4pt;   height:107.65pt" valign="top" width="94"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB" style="color:black"><img border="0" height="140" id="Picture 27" src="#image24" width="89"/></span></p> </td> <td style="width:190.6pt;padding:0in 5.4pt 0in 5.4pt;   height:107.65pt" valign="top" width="254"> <p class="MsoNormal"></p> <p class="MsoNormal"></p> <p class="MsoNormal"><span lang="EN-GB">Expel air until suspension fills needle   base*</span></p> </td> </tr> </table><p class="MsoNormal"></p><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:28.35pt;text-indent:-28.35pt"><em><span lang="EN-GB" style="color:black;font-style:normal">f)       Slowly inject into the gluteal or deltoid muscle. Do not massage the injection site. Care must be taken to avoid inadvertent injection into the blood vessel. Do not inject into an area with signs of inflammation, skin damage, lumps and/or bruises. </span></em><span lang="EN-GB" style="color:black">For deep intramuscular gluteal or deltoid injection only.</span></p><p align="center" class="MsoNormal" style="margin-left:28.35pt;text-align:center"></p><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="width:424.85pt;margin-left:33.75pt;border-collapse:collapse" width="566"> <tr> <td colspan="2" style="width:424.85pt;padding:0in 5.4pt 0in 5.4pt" width="566"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB" style="color:black"><img alt="ws" border="0" height="202" id="Bild 23" src="#image25" width="443"/></span></p> </td> </tr> <tr> <td style="width:194.7pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="260"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">deltoid</span></em></p> </td> <td style="width:230.15pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p align="center" class="MsoNormal" style="text-align:center"><em><span lang="EN-GB" style="color:black;font-style:normal">gluteal</span></em></p> </td> </tr> </table><p class="MsoNormal"></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB" style="color:black">Remember to rotate sites of injections between the two gluteal or deltoid muscles. </span></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB" style="color:black">If initiating with the two injection start, inject into two different sites in two different muscles. </span><span lang="EN-GB">DO NOT inject both injections concomitantly into the same deltoid or gluteal muscle.</span></p><p class="MsoNormal" style="margin-left:31.5pt"><span lang="EN-GB">For known CYP2D6 poor metabolisers administer in either<s> </s>two separate deltoid muscles or one deltoid and one gluteal muscle.</span><span lang="EN-GB">DO NOT inject into two gluteal muscles.</span></p><p class="MsoNormal" style="margin-left:31.5pt"><em><span lang="EN-GB" style="color:black;font-style:normal">Look for signs or symptoms of inadvertent intravenous administration.</span></em></p><p class="MsoNormal" style="margin-left:31.5pt"></p><p class="MsoNormal"><em><u><span lang="EN-GB" style="color:black;font-style:normal">Step 4: Procedures after injection</span></u></em></p><p class="MsoNormal" style="text-autospace:none"><span lang="EN-GB" style="color:black">Engage the needle safety device. Dispose of the needle and pre‑filled syringe appropriately after injection.</span></p><p class="MsoNormal" style="text-autospace:none"></p><div align="center"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:313.35pt;padding:0in 5.4pt 0in 5.4pt" width="418"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="123" id="Bild 24" src="#image26" width="291"/></span></p> </td> </tr> <tr> <td style="width:313.35pt;padding:0in 5.4pt 0in 5.4pt" width="418"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse"> <tr> <td style="width:196.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="262"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:230.15pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table> <p class="MsoNormal" style="text-autospace:none"></p> </td> </tr> </table> </div><table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-collapse:collapse"> <tr> <td style="width:313.35pt;padding:0in 5.4pt 0in 5.4pt" width="418"> <p align="center" class="MsoNormal" style="text-align:center;text-autospace:none"><span lang="EN-GB" style="color:black"><img border="0" height="123" id="Bild 24" src="#image27" width="291"/></span></p> </td> </tr> <tr> <td style="width:313.35pt;padding:0in 5.4pt 0in 5.4pt" width="418"> <table border="0" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="margin-left:33.75pt;border-collapse:collapse"> <tr> <td style="width:196.4pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="262"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Cover</span></p> </td> <td style="width:230.15pt;padding:0in 5.4pt 0in 5.4pt" valign="top" width="307"> <p align="center" class="MsoNormal" style="text-align:center"><span lang="EN-GB">Discard</span></p> </td> </tr> </table> <p class="MsoNormal" style="text-autospace:none"></p> </td> </tr> </table><p class="MsoNormal" style="margin-right:-.05pt;text-autospace:none"></p>
			</div>
		</text>
		
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
</section>
			    
    	    
		
	
</section>
							<!-- sections can repeat as necessary -->
						</Composition>
					</resource>
				</entry>
				
			</Bundle>
		</resource>
	</entry>
</Bundle>